ERBB2 and breast carcinoma: Gene expression profiling has identified intrinsic molecular phenotypes of breast cancer that subclassify ER+ tumours into two main subtypes that predict outcome: luminal A and B, which can be distinguished by the presence of increased proliferation, HER-2 amplification and a less favourable prognosis in the latter group (Sorlie et al, 2001).